These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 34517533)

  • 1. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Analysis of CXC Chemokine-Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis.
    Situ Y; Lu X; Cui Y; Xu Q; Deng L; Lin H; Shao Z; Chen J
    Biomed Res Int; 2022; 2022():5137301. PubMed ID: 36246978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment.
    Zhou X; Peng M; He Y; Peng J; Zhang X; Wang C; Xia X; Song W
    Front Oncol; 2021; 11():619003. PubMed ID: 33767987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
    Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
    Front Oncol; 2019; 9():1555. PubMed ID: 32117786
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
    Yin Z; Ma T; Chen S; Yu M
    Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma.
    Huang J; Chen Z; Ding C; Lin S; Wan D; Ren K
    Front Oncol; 2021; 11():711402. PubMed ID: 34497764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma.
    Li Y; Wu T; Gong S; Zhou H; Yu L; Liang M; Shi R; Wu Z; Zhang J; Li S
    Front Oncol; 2020; 10():570736. PubMed ID: 33489879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma.
    Wang K; Li R; Zhang Y; Qi W; Fang T; Yue W; Tian H
    Int J Gen Med; 2022; 15():2283-2300. PubMed ID: 35250303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature.
    Korbecki J; Kojder K; Kapczuk P; Kupnicka P; Gawrońska-Szklarz B; Gutowska I; Chlubek D; Baranowska-Bosiacka I
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10.
    Li W; Ma JA; Sheng X; Xiao C
    World J Surg Oncol; 2021 Nov; 19(1):329. PubMed ID: 34794429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in Pancreatic Ductal Adenocarcinoma Microenvironment.
    Yin Z; Chen S
    Pancreas; 2022 Oct; 51(9):1235-1247. PubMed ID: 37078951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics Analysis of Potential Therapeutic Targets and Prognostic Biomarkers amid CXC Chemokines in Ovarian Carcinoma Microenvironment.
    Jin Y; Lin Q; Fei H; Xue L; Li L; Xi Q; Jiang H
    J Oncol; 2021; 2021():8859554. PubMed ID: 33763130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
    Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
    Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment.
    Kong W; Zhao G; Chen H; Wang W; Shang X; Sun Q; Guo F; Ma X
    Cancer Cell Int; 2021 Jul; 21(1):399. PubMed ID: 34321012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CXC group chemokines in lung cancer development and progression.
    Spaks A
    J Thorac Dis; 2017 Apr; 9(Suppl 3):S164-S171. PubMed ID: 28446981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advance in the role of chemokines/chemokine receptors in carcinogenesis: Focus on pancreatic cancer.
    Song N; Cui K; Zeng L; Li M; Fan Y; Shi P; Wang Z; Su W; Wang H
    Eur J Pharmacol; 2024 Mar; 967():176357. PubMed ID: 38309677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of the prognosis and immune infiltration for CXC chemokines in colorectal cancer.
    Yang X; Wei Y; Sheng F; Xu Y; Liu J; Gao L; Yang J; Sun X; Huang J; Guo Q
    Aging (Albany NY); 2021 Jul; 13(13):17548-17567. PubMed ID: 34233297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
    Wu C; Ma C; Yuan J; Zhou P
    Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma.
    Zhou X; Guo S; Shi Y
    Sci Rep; 2022 Feb; 12(1):2817. PubMed ID: 35181719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.